Home/Rare Diseases/Hypoparathyroidism

Endocrine & Hormonal

Hypoparathyroidism Clinical Trials and Treatments

Also called Parathyroid Insufficiency, Hypocalcemia with Hyperphosphatemia, Chronic Hypoparathyroidism

Hypoparathyroidism disrupts the body's calcium regulation system. Normally, the four parathyroid glands (tiny structures behind the thyroid) secrete PTH in response to falling blood calcium.

View 40 active trialsMatch me to a trial

About Hypoparathyroidism

Hypoparathyroidism disrupts the body's calcium regulation system. Normally, the four parathyroid glands (tiny structures behind the thyroid) secrete PTH in response to falling blood calcium. PTH then raises calcium by pulling it from bones, increasing kidney reabsorption, and activating vitamin D to boost intestinal calcium absorption. When PTH is absent or insufficient, blood calcium drops and phosphorus rises, creating a state of neuromuscular irritability that can range from mild tingling to life-threatening seizures and cardiac arrhythmias.

For decades, treatment was limited to high-dose calcium and active vitamin D supplements, which manage symptoms but don't restore normal physiology and carry risks of kidney damage from excess calcium in the urine. In August 2024, the FDA approved Yorvipath (palopegteriparatide), developed by Ascendis Pharma, as the first and only currently available PTH replacement therapy for adults with chronic hypoparathyroidism. Yorvipath is a once-daily subcutaneous injection that releases a PTH analog to restore more normal calcium regulation. An earlier PTH replacement, Natpara (rhPTH[1-84]), was recalled in 2019 due to rubber particulate contamination and was ultimately discontinued by Takeda at the end of 2024.

Common Symptoms of Hypoparathyroidism

Recognizing the signs of Hypoparathyroidism early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.

  • Tingling and numbness around the mouth, hands, and feet (paresthesias)
  • Muscle cramps and spasms, particularly in the hands and feet (carpopedal spasms)
  • Tetany with uncontrollable muscle twitching and cramping
  • Seizures in more severe or untreated cases
  • Laryngospasm (spasm of the voice box) causing breathing difficulty
  • Cardiac arrhythmias from prolonged low calcium levels
  • Chronic fatigue and generalized weakness
  • Anxiety, depression, and difficulty concentrating (brain fog)
  • Brittle nails, dry skin, and coarse hair
  • Kidney stones and calcium deposits in soft tissues over time

Who Hypoparathyroidism Affects

Hypoparathyroidism can occur at any age. The majority of cases result from surgical complications during thyroidectomy, parathyroidectomy, or other neck procedures. The remaining cases are genetic (including DiGeorge syndrome from 22q11.2 deletion), autoimmune, or idiopathic.

It affects males and females, though postsurgical cases are more common in women. Genetic forms can follow autosomal dominant or autosomal recessive inheritance patterns.

Find Your Next Step

Answer a few questions and we'll point you to the right tools and information for where you are right now.

Where are you in your Hypoparathyroidism journey?

FDA-Approved Treatments for Hypoparathyroidism

There is currently 1 FDA-approved medication for Hypoparathyroidism. These therapies represent the current standard of care and may be used alongside or compared against investigational treatments in active clinical trials.

palopegteriparatide
Ascendis Pharma
Search

Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.

Ask about these treatments
Answers with sources, in plain English
Start withor ask

Help Paying for Hypoparathyroidism Treatment

Charity funds and drugmaker programs for Hypoparathyroidism, checked at the source. Pick your insurance to see what fits.

Your insurance
Charity funds
  • From a charity · The Assistance Fund
    Hypoparathyroidism fund
    Open

    Pays for: Copays, coinsurance, deductibles and other health-related expenses.

    The foundation says: “OPEN — Accepting New Patients. TAF is currently accepting new patient enrollments for this program.”
Status as each foundation showed it on October 5, 2026.
Drugmaker programs
Open a medicine for who qualifies, by insurance type.

Open the full patient assistance finder →

Side Effect Explorer

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Questions about side effects?
I can help you understand what these reports mean
Start withor ask

Genetic Testing

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Hypoparathyroidism Resources

Reputable organizations and medical references for learning more about Hypoparathyroidism, including disease registries, foundation resources, and clinical guidelines.

Active Clinical Trials for Hypoparathyroidism

Use this Hypoparathyroidism clinical trial finder to see the 31 studies recruiting patients and 4 opening soon in the United States and worldwide, with eligibility criteria in plain English. These studies play a critical role in advancing care for endocrine & hormonal conditions and may offer access to treatments not yet widely available. Each trial below is sourced directly from ClinicalTrials.gov, with eligibility criteria translated into plain English to help patients and caregivers evaluate whether a study may be a fit.

TrialsSite mapPipeline timeline

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

40 active trials worldwide
Filter:
Sort:
RECRUITINGRecently updatedNCT07857460

German Hypoparathyroidism Registry

Sponsor: University Hospital Augsburg · Ascendis Pharma Endocrinology Division A/S

Chronic hypoparathyroidism is a rare condition in which the parathyroid glands do not make enough parathyroid hormone (PTH). PTH helps control the levels of calcium and phosphate in the blood. When there is not enough PTH, calcium levels can become too low and phosphate levels ca...

Ages 18 Years+1 location
Started Jul 2021Updated 2 days agoEst. Feb 2036 (~9y 3m)
RECRUITINGPHASE3Recently updatedNCT07081997

A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

Intervention: Palopegteriparatide Experimental Arm, Palopegteriparatide Control Arm

Sponsor: Ascendis Pharma Bone Diseases A/S

This trial has a treatment duration of 78 weeks and will include adult participants already on treatment with palopegteriparatide at doses at or greater than 30 mcg/day. All participants will receive subcutaneous palopegteriparatide during the trial and will be individually and p...

Ages 18 Years+8 locations
Started May 2026Updated 1 week agoEst. Jun 2027 (~8 months)
RECRUITINGPHASE3Recently updatedNCT07699471

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

Intervention: Canvuparatide, Placebo

Sponsor: MBX Biosciences

The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).

Ages 18 Years+12 locations
Started Aug 2026Updated 1 week agoEst. Jan 2028 (~1y 3m)
RECRUITINGRecently updatedNCT07428057

Postoperative Hypocalcemia After Thyroidectomy

Sponsor: Minia University

This retrospective cohort study investigates predictors of postoperative hypocalcemia following thyroidectomy procedures at Minia University Hospital over a 10-year period (2014-2024). Postthyroidectomy hypocalcemia is one of the most common complications of thyroid surgery, affe...

Ages 18 Years – 75 Years1 location
Started Jan 2014Updated 2 weeks agoEst. Dec 2026 (~1 month)
RECRUITINGPHASE3Recently updatedNCT07805356

Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism

Intervention: Encaleret, Placebo

Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company

The aim of the study is to evaluate the efficacy, safety, and tolerability of orally administered encaleret tablets in participants with chronic hypoparathyroidism (HP).

Ages 16 Years+5 locations
Expected to start Aug 2026Updated 3 weeks agoEst. Jan 2028 (~1y 3m)
Get trial alerts

Get notified when new Hypoparathyroidism trials open or existing trials change status, add sites, or update eligibility.

We never share your email. Unsubscribe anytime.
Find Hypoparathyroidism trials near you, ranked by distance →
Active trial locations30 cities in the US
+22 more

Trial Pipeline

Jan 2021 to Oct 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Phase 3
Phase 4
Observational
Observational
RecruitingOpening soonDelayed startTodayHover a bar for trial details
Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Hypoparathyroidism foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Patient Communities

Connect with other Hypoparathyroidism patients, caregivers, and advocacy groups across Facebook groups, Reddit communities, and YouTube channels. These patient communities offer peer support, shared experiences, caregiver resources, and real-time discussion about Hypoparathyroidism treatments, clinical trial participation, and day-to-day disease management.

Find the right community
Answers with sources, in plain English
Start withor ask

Related Endocrine & Hormonal Conditions

Other rare diseases in the endocrine & hormonal category. Patients with Hypoparathyroidism may find relevant research, shared treatment pathways, or overlapping clinical trials among these related conditions.

Companies Developing Hypoparathyroidism Treatments

5 pharmaceutical companies have Hypoparathyroidism in their rare disease portfolio

Frequently Asked Questions About Hypoparathyroidism